+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Direct Oral Anticoagulants Market - Global Forecast 2025-2030- Product Image
Direct Oral Anticoagulants Market - Global Forecast 2025-2030- Product Image
Sale

Direct Oral Anticoagulants Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140259
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The direct oral anticoagulant (DOAC) market is experiencing a period of significant transformation, driven by clinical innovation, regulatory developments, and technology-enabled care. Senior leaders require targeted insights into evolving drug classes, dynamic competition, and supply chain adjustments shaping this sector.

Market Snapshot: Direct Oral Anticoagulant Market Overview

The global direct oral anticoagulant market, characterized by the uptake of agents with improved safety profiles and simplified management, is growing steadily. Evolving healthcare systems and the expansion of novel therapies in chronic disease management reinforce market momentum. Adoption is particularly strong across atrial fibrillation and venous thromboembolism indications, where providers and patients prioritize efficacy, adherence, and real-world usability.

Scope & Segmentation

This report offers comprehensive coverage with a focus on core molecular agents, user environments, and evolving technologies.

  • Molecules: Apixaban, Dabigatran, Edoxaban, Rivaroxaban
  • Indications: Stroke Prevention in Atrial Fibrillation (Nonvalvular), Venous Thromboembolism Prevention (Medical Patients, Orthopedic Surgery: Hip Replacement, Knee Replacement), Venous Thromboembolism Treatment (Deep Vein Thrombosis, Pulmonary Embolism)
  • End Users: Hospitals, Clinics, Home Healthcare
  • Distribution Channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
  • Mechanism of Action: Direct Thrombin Inhibitor, Factor Xa Inhibitor
  • Route of Administration: Capsule, Tablet
  • Geographies: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Bayer AG, Böhringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Pfizer Inc., Johnson & Johnson, Daiichi Sankyo Co., Ltd.

Key Takeaways for Decision-Makers

  • Widespread adoption of DOACs is fueled by predictable pharmacokinetics and minimized monitoring requirements compared to traditional therapies.
  • Biosimilars and generics are accelerating price competition and promoting investment in patient support, adherence tools, and differentiated value offerings.
  • Digital health integration is transforming therapy management: mobile adherence apps, telemedicine consultations, and real-time remote monitoring now facilitate improved compliance and earlier detection of adverse events.
  • Personalized medicine is shaping dosing decisions, utilizing pharmacogenomics and AI-powered risk models for more patient-specific regimens.
  • Strategic partnerships between pharmaceutical firms, digital health companies, and healthcare providers are now essential for the delivery of integrated patient-centric solutions.
  • Regional dynamics—such as advanced reimbursement models in the Americas, centralized procurement in Europe, and growing telemedicine adoption in Asia-Pacific—influence uptake and access strategies.

Tariff Impact: Effects of 2025 U.S. Trade Policy

In 2025, new tariffs on active pharmaceutical ingredients in the United States prompted a shift in sourcing and manufacturing approaches. Companies have responded by diversifying suppliers, exploring domestic production, and renegotiating reimbursement models to balance operational costs and patient access. Some firms are absorbing additional costs, while others are introducing tiered pricing and bundled service offerings. Regulatory agencies have expedited reviews to avoid supply chain disruptions and preserve therapy availability across patient populations.

Methodology & Data Sources

Market assessment employs a blend of quantitative and qualitative research. Secondary data from peer-reviewed publications, clinical trials, and regulatory filings is complemented by primary interviews with medical leaders and advocacy groups. Advanced scenario modeling and competitive intelligence provide additional insights on trade policy repercussions and evolving market structures.

Why This Report Matters

  • Enables executives to benchmark competitive portfolios against evolving clinical and commercial best practices.
  • Supports informed investment, manufacturing, and go-to-market decisions in light of shifting pricing and regulatory landscapes.
  • Equips leadership with actionable strategies to align digital health capabilities, regional compliance, and patient engagement efforts for ongoing success.

Conclusion

Direct oral anticoagulant therapies continue to advance through scientific innovation, regulatory adaptation, and patient-focused delivery models. Senior stakeholders can harness this report to anticipate developments and refine strategic priorities in a rapidly changing market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Evaluating the clinical benefits and adoption barriers of once-daily versus twice-daily DOAC regimens
5.2. Analyzing cost-effectiveness and reimbursement challenges for DOAC use in emerging markets
5.3. Tracking real-world evidence on DOAC safety profiles in patients with renal impairment
5.4. Examining strategies for managing drug-drug interactions between DOACs and targeted oncology therapies
5.5. Assessing the potential of emerging DOAC reversal agents to influence prescribing trends
5.6. Forecasting the impact of impending DOAC patent expirations on global pricing dynamics
5.7. Identifying commercial opportunities for novel oral anticoagulant formulations to boost patient adherence
5.8. Evaluating integration of telehealth and digital adherence tools in DOAC therapy management protocols
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Direct Oral Anticoagulants Market, by Molecule
8.1. Introduction
8.2. Apixaban
8.3. Dabigatran
8.4. Edoxaban
8.5. Rivaroxaban
9. Direct Oral Anticoagulants Market, by Indication
9.1. Introduction
9.2. Stroke Prevention In Atrial Fibrillation
9.2.1. Nonvalvular Atrial Fibrillation
9.3. Venous Thromboembolism Prevention
9.3.1. Medical Patients
9.3.2. Orthopedic Surgery
9.3.2.1. Hip Replacement
9.3.2.2. Knee Replacement
9.4. Venous Thromboembolism Treatment
9.4.1. Deep Vein Thrombosis
9.4.2. Pulmonary Embolism
10. Direct Oral Anticoagulants Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Healthcare
10.4. Hospitals
11. Direct Oral Anticoagulants Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Direct Oral Anticoagulants Market, by Mechanism Of Action
12.1. Introduction
12.2. Direct Thrombin Inhibitor
12.3. Factor Xa Inhibitor
13. Direct Oral Anticoagulants Market, by Route Of Administration
13.1. Introduction
13.2. Capsule
13.3. Tablet
14. Americas Direct Oral Anticoagulants Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Direct Oral Anticoagulants Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Direct Oral Anticoagulants Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bayer AG
17.3.2. Bo¨hringer Ingelheim International GmbH
17.3.3. Bristol-Myers Squibb Company
17.3.4. Pfizer Inc.
17.3.5. Johnson & Johnson
17.3.6. Daiichi Sankyo Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DIRECT ORAL ANTICOAGULANTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIRECT ORAL ANTICOAGULANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIRECT ORAL ANTICOAGULANTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DIRECT ORAL ANTICOAGULANTS MARKET: RESEARCHAI
FIGURE 28. DIRECT ORAL ANTICOAGULANTS MARKET: RESEARCHSTATISTICS
FIGURE 29. DIRECT ORAL ANTICOAGULANTS MARKET: RESEARCHCONTACTS
FIGURE 30. DIRECT ORAL ANTICOAGULANTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIRECT ORAL ANTICOAGULANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY APIXABAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY APIXABAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DABIGATRAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DABIGATRAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY EDOXABAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY EDOXABAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY RIVAROXABAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY RIVAROXABAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY NONVALVULAR ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY NONVALVULAR ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MEDICAL PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MEDICAL PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DIRECT THROMBIN INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DIRECT THROMBIN INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY FACTOR XA INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY FACTOR XA INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 122. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 123. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 128. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 129. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 130. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 131. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 132. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 133. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 138. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 139. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 150. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 151. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 152. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 153. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 254. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 255. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. GERMANY DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 272. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 273. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 274. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 275. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 280. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 281. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. FRANCE DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM TREATMENT, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA DIRECT ORAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Direct Oral Anticoagulants market report include:
  • Bayer AG
  • Böhringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Johnson & Johnson
  • Daiichi Sankyo Co., Ltd.

Related Topics

Related Reports

Anticoagulants Market - Global Forecast 2025-2030 - Product Image

Anticoagulants Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Anticoagulants Market Report 2025 - Product Image

Anticoagulants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 125 Pages
  • Global
From
Anticoagulants - Global Strategic Business Report - Product Image

Anticoagulants - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.